BioSyent Inc. (RX.V)
CAD 11.64
(-0.94%)
CAD 11.64
(-0.94%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 5.89 Million CAD | 29.97% |
| 2022 | 4.53 Million CAD | 105.75% |
| 2021 | 2.2 Million CAD | 6.31% |
| 2020 | 2.07 Million CAD | -3.07% |
| 2019 | 2.13 Million CAD | 44.21% |
| 2018 | 1.48 Million CAD | 63.22% |
| 2017 | 908.82 Thousand CAD | -41.74% |
| 2016 | 1.56 Million CAD | -10.6% |
| 2015 | 1.74 Million CAD | 37.19% |
| 2014 | 1.27 Million CAD | 143.29% |
| 2013 | 522.78 Thousand CAD | 51.26% |
| 2012 | 345.63 Thousand CAD | 184.98% |
| 2011 | 121.28 Thousand CAD | 108.06% |
| 2010 | 58.29 Thousand CAD | -49.23% |
| 2009 | 114.82 Thousand CAD | 5.78% |
| 2008 | 108.54 Thousand CAD | -14.4% |
| 2007 | 126.79 Thousand CAD | 245.68% |
| 2006 | 36.68 Thousand CAD | 3.62% |
| 2005 | 35.4 Thousand CAD | -25.72% |
| 2004 | 47.65 Thousand CAD | -32.07% |
| 2003 | 70.15 Thousand CAD | -36.3% |
| 2002 | 110.14 Thousand CAD | 36.49% |
| 2001 | 80.69 Thousand CAD | 13.49% |
| 2000 | 71.1 Thousand CAD | -28.9% |
| 1999 | 100 Thousand CAD | -50.0% |
| 1998 | 200 Thousand CAD | 0.0% |
| 1997 | 200 Thousand CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 5.71 Million CAD | -2.98% |
| 2024 Q2 | 6.02 Million CAD | 5.43% |
| 2023 Q3 | 4.56 Million CAD | 8.14% |
| 2023 Q4 | 5.89 Million CAD | 29.16% |
| 2023 Q1 | 4.7 Million CAD | 3.81% |
| 2023 FY | 5.89 Million CAD | 29.97% |
| 2023 Q2 | 4.22 Million CAD | -10.37% |
| 2022 Q4 | 4.53 Million CAD | 8.76% |
| 2022 Q2 | 2.77 Million CAD | 4.45% |
| 2022 Q3 | 4.17 Million CAD | 50.25% |
| 2022 FY | 4.53 Million CAD | 105.75% |
| 2022 Q1 | 2.65 Million CAD | 20.55% |
| 2021 Q1 | 2.7 Million CAD | 30.51% |
| 2021 FY | 2.2 Million CAD | 6.31% |
| 2021 Q3 | 2.46 Million CAD | 9.38% |
| 2021 Q2 | 2.25 Million CAD | -16.55% |
| 2021 Q4 | 2.2 Million CAD | -10.75% |
| 2020 Q1 | 1.52 Million CAD | -28.78% |
| 2020 FY | 2.07 Million CAD | -3.07% |
| 2020 Q3 | 1.24 Million CAD | -31.74% |
| 2020 Q2 | 1.82 Million CAD | 19.95% |
| 2020 Q4 | 2.07 Million CAD | 66.24% |
| 2019 Q3 | 2.1 Million CAD | 1.77% |
| 2019 Q4 | 2.13 Million CAD | 1.62% |
| 2019 Q2 | 2.06 Million CAD | 3.85% |
| 2019 Q1 | 1.99 Million CAD | 34.27% |
| 2019 FY | 2.13 Million CAD | 44.21% |
| 2018 Q3 | 1.34 Million CAD | -22.73% |
| 2018 Q4 | 1.48 Million CAD | 10.7% |
| 2018 FY | 1.48 Million CAD | 63.22% |
| 2018 Q1 | 1.19 Million CAD | 31.37% |
| 2018 Q2 | 1.73 Million CAD | 45.26% |
| 2017 FY | 908.82 Thousand CAD | -41.74% |
| 2017 Q2 | 1.48 Million CAD | -14.68% |
| 2017 Q3 | 1.27 Million CAD | -13.97% |
| 2017 Q4 | 908.82 Thousand CAD | -28.72% |
| 2017 Q1 | 1.73 Million CAD | 11.34% |
| 2016 Q4 | 1.56 Million CAD | 0.96% |
| 2016 FY | 1.56 Million CAD | -10.6% |
| 2016 Q3 | 1.54 Million CAD | -11.66% |
| 2016 Q1 | 1.79 Million CAD | 2.8% |
| 2016 Q2 | 1.74 Million CAD | -2.48% |
| 2015 Q4 | 1.74 Million CAD | 4.04% |
| 2015 Q1 | 1.7 Million CAD | 33.91% |
| 2015 Q2 | 2.21 Million CAD | 29.97% |
| 2015 Q3 | 1.67 Million CAD | -24.23% |
| 2015 FY | 1.74 Million CAD | 37.19% |
| 2014 Q4 | 1.27 Million CAD | 81.24% |
| 2014 Q2 | 814.11 Thousand CAD | 31.48% |
| 2014 Q3 | 701.76 Thousand CAD | -13.8% |
| 2014 FY | 1.27 Million CAD | 143.29% |
| 2014 Q1 | 619.19 Thousand CAD | 18.44% |
| 2013 FY | 522.78 Thousand CAD | 51.26% |
| 2013 Q3 | 637.06 Thousand CAD | -20.06% |
| 2013 Q4 | 522.78 Thousand CAD | -17.94% |
| 2013 Q1 | 327.13 Thousand CAD | -5.35% |
| 2013 Q2 | 796.9 Thousand CAD | 143.6% |
| 2012 Q4 | 345.63 Thousand CAD | -15.5% |
| 2012 Q3 | 409.03 Thousand CAD | -7.97% |
| 2012 Q2 | 444.44 Thousand CAD | 75.29% |
| 2012 FY | 345.63 Thousand CAD | 184.98% |
| 2012 Q1 | 253.54 Thousand CAD | 109.05% |
| 2011 FY | 121.28 Thousand CAD | 108.06% |
| 2011 Q4 | 121.28 Thousand CAD | -34.29% |
| 2011 Q3 | 184.58 Thousand CAD | 19.23% |
| 2011 Q2 | 154.81 Thousand CAD | 71.44% |
| 2011 Q1 | 90.3 Thousand CAD | 54.92% |
| 2010 Q4 | 58.29 Thousand CAD | -5.11% |
| 2010 FY | 58.29 Thousand CAD | -49.23% |
| 2010 Q1 | 68.47 Thousand CAD | -40.37% |
| 2010 Q2 | 103.37 Thousand CAD | 50.97% |
| 2010 Q3 | 61.43 Thousand CAD | -40.57% |
| 2009 Q4 | 114.82 Thousand CAD | 13.41% |
| 2009 Q2 | 159.21 Thousand CAD | 11.03% |
| 2009 Q3 | 101.24 Thousand CAD | -36.41% |
| 2009 FY | 114.82 Thousand CAD | 5.78% |
| 2009 Q1 | 143.4 Thousand CAD | 32.11% |
| 2008 Q2 | 173.92 Thousand CAD | 61.44% |
| 2008 Q3 | 142.19 Thousand CAD | -18.24% |
| 2008 Q4 | 108.54 Thousand CAD | -23.67% |
| 2008 FY | 108.54 Thousand CAD | -14.4% |
| 2008 Q1 | 107.73 Thousand CAD | -15.03% |
| 2007 Q2 | 102.23 Thousand CAD | 103.55% |
| 2007 Q1 | 50.22 Thousand CAD | 36.93% |
| 2007 FY | 126.79 Thousand CAD | 245.68% |
| 2007 Q4 | 126.79 Thousand CAD | 1.94% |
| 2007 Q3 | 124.38 Thousand CAD | 21.67% |
| 2006 FY | 36.68 Thousand CAD | 3.62% |
| 2006 Q1 | 38.06 Thousand CAD | 7.53% |
| 2006 Q3 | 42.44 Thousand CAD | 118.58% |
| 2006 Q2 | 19.41 Thousand CAD | -48.99% |
| 2006 Q4 | 36.68 Thousand CAD | -13.58% |
| 2005 FY | 35.4 Thousand CAD | -25.72% |
| 2005 Q2 | 50.96 Thousand CAD | 117.72% |
| 2005 Q1 | 23.4 Thousand CAD | -50.88% |
| 2005 Q3 | 52.45 Thousand CAD | 2.93% |
| 2005 Q4 | 35.4 Thousand CAD | -32.52% |
| 2004 Q4 | 47.65 Thousand CAD | -19.75% |
| 2004 Q3 | 59.38 Thousand CAD | -15.64% |
| 2004 Q2 | 70.39 Thousand CAD | 4.01% |
| 2004 Q1 | 67.68 Thousand CAD | -3.52% |
| 2004 FY | 47.65 Thousand CAD | -32.07% |
| 2003 Q4 | 70.15 Thousand CAD | -88.0% |
| 2003 FY | 70.15 Thousand CAD | -36.3% |
| 2003 Q3 | 584.44 Thousand CAD | 3.58% |
| 2003 Q2 | 564.24 Thousand CAD | -2.8% |
| 2003 Q1 | 580.49 Thousand CAD | 427.03% |
| 2002 FY | 110.14 Thousand CAD | 36.49% |
| 2002 Q1 | 74.62 Thousand CAD | -7.52% |
| 2002 Q2 | 66.42 Thousand CAD | -10.99% |
| 2002 Q3 | 85.19 Thousand CAD | 28.26% |
| 2002 Q4 | 110.14 Thousand CAD | 29.29% |
| 2001 Q3 | 91.54 Thousand CAD | 12.93% |
| 2001 Q4 | 80.69 Thousand CAD | -11.86% |
| 2001 FY | 80.69 Thousand CAD | 13.49% |
| 2001 Q1 | 89.13 Thousand CAD | 25.36% |
| 2001 Q2 | 81.06 Thousand CAD | -9.05% |
| 2000 Q4 | 71.1 Thousand CAD | -32.26% |
| 2000 FY | 71.1 Thousand CAD | -28.9% |
| 2000 Q2 | 100 Thousand CAD | 0.0% |
| 2000 Q3 | 104.96 Thousand CAD | 4.97% |
| 2000 Q1 | 100 Thousand CAD | 0.0% |
| 1999 FY | 100 Thousand CAD | -50.0% |
| 1999 Q1 | 200 Thousand CAD | 0.0% |
| 1999 Q3 | 100 Thousand CAD | -50.0% |
| 1999 Q4 | 100 Thousand CAD | 0.0% |
| 1999 Q2 | 200 Thousand CAD | 0.0% |
| 1998 Q2 | 300 Thousand CAD | 50.0% |
| 1998 Q3 | 200 Thousand CAD | -33.33% |
| 1998 Q1 | 200 Thousand CAD | 0.0% |
| 1998 Q4 | 200 Thousand CAD | 0.0% |
| 1998 FY | 200 Thousand CAD | 0.0% |
| 1997 FY | 200 Thousand CAD | 0.0% |
| 1997 Q3 | 200 Thousand CAD | 0.0% |
| 1997 Q4 | 200 Thousand CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 123.74 Thousand CAD | -4663.382% |
| CanadaBis Capital Inc. | 5.82 Million CAD | -1.14% |
| Decibel Cannabis Company Inc. | 48.7 Million CAD | 87.898% |
| Delivra Health Brands Inc. | 1.47 Million CAD | -298.816% |
| Entourage Health Corp. | 10.01 Million CAD | 41.116% |
| Lifeist Wellness Inc. | 4.51 Million CAD | -30.665% |
| Cannara Biotech Inc. | 33.77 Million CAD | 82.546% |
| Medicure Inc. | 2.9 Million CAD | -103.258% |
| PharmaCielo Ltd. | 2.31 Million CAD | -155.048% |
| Rubicon Organics Inc. | 11.27 Million CAD | 47.739% |
| Voyageur Pharmaceuticals Ltd. | 10.32 Thousand CAD | -57000.601% |